18人のウォール街のアナリストによると、Hinge Health Incの収益見積もりは$193.08Mから$168.46Mの範囲です。
Hinge Health Incの収益品質スコアはどれくらいですか?
Hinge Health Incの収益品質スコアはB+/44.793114です。このスコアは、収益性、成長、キャッシュ生成と資本配分、レバレッジの4つの次元に基づいています。
Hinge Health Incはいつ収益を報告しますか?
Hinge Health Incの次の収益報告は2026-05-11に予定されています
Hinge Health Incの予想収益はいくらですか?
ウォール街のアナリストによると、Hinge Health Incの予想収益は$159.77Mです。
Hinge Health Incは収益予想を上回りましたか?
Hinge Health Incの最近の収益は$170.72Mで、予想をビート。
主要データ
前終値
$38.56
始値
$39
当日レンジ
$37.8 - $39.19
52週レンジ
$30.08 - $62.18
取引高
382.7K
平均取引高
1.2M
配当利回り
--
1株当たり利益(TTM)
-12.53
時価総額
$3.0B
HNGEとは何ですか?
Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. The company is headquartered in San Francisco, California. The company went IPO on 2025-05-22. The firm has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. The company offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.